Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial. (2019)
Attributed to:
Epidemiological and statistical research on health problems of developing countries: MRC Tropical Epidemiology Group
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/cid/ciy589
PubMed Identifier: 30060027
Publication URI: http://europepmc.org/abstract/MED/30060027
Type: Journal Article/Review
Volume: 68
Parent Publication: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Issue: 7
ISSN: 1058-4838